BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2907171)

  • 21. Calcitonin gene-related peptides I and II and calcitonin: distinct effects on gastric acid secretion in humans.
    Beglinger C; Born W; Hildebrand P; Ensinck JW; Burkhardt F; Fischer JA; Gyr K
    Gastroenterology; 1988 Oct; 95(4):958-65. PubMed ID: 2900791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitonin gene-related peptide and induction of hyperglycemia in conscious rats in vivo.
    Yamaguchi A; Chiba T; Morishita T; Nakamura A; Inui T; Yamatani T; Kadowaki S; Chihara K; Fukase M; Fujita T
    Diabetes; 1990 Feb; 39(2):168-74. PubMed ID: 2227123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin modulation of insulin and glucagon secretion in man.
    Giugliano D; Passariello N; Sgambato S; Torella R; D'Onofrio F
    Am J Physiol; 1982 Mar; 242(3):E206-13. PubMed ID: 7039348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and molecular characterization of porcine calcitonin gene-related peptide (CGRP) and its endocrine effects in the porcine pancreas.
    Rasmussen TN; Bersani M; Schmidt P; Thim L; Kofod H; Jørgensen PN; Poulsen SS; Holst JJ
    Pancreas; 1998 Mar; 16(2):195-204. PubMed ID: 9510144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
    Gosmanov NR; Szoke E; Israelian Z; Smith T; Cryer PE; Gerich JE; Meyer C
    Diabetes Care; 2005 May; 28(5):1124-31. PubMed ID: 15855577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin and glucagon secretion in swimming mice: effects of autonomic receptor antagonism.
    Karlsson S; Ahrén B
    Metabolism; 1990 Jul; 39(7):724-32. PubMed ID: 1973257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
    Lien E; Sarantakis D
    Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of insulin secretion during selective blockade of alpha 1- and alpha 2-adrenoceptors in the rat: effects of somatostatin.
    Ahrén B; Järhult J; Lundquist I
    Acta Physiol Scand; 1982 Jun; 115(2):257-60. PubMed ID: 6127872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas.
    Szecówka J; Sandberg E; Efendić S
    Diabetologia; 1980 Aug; 19(2):137-42. PubMed ID: 6106616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of pancreatic exocrine secretion in the rat by calcitonin gene-related peptide: involvement of circulating somatostatin.
    Mulholland MW; Garcia R; Garcia I; Taborsky GJ; Helton S
    Endocrinology; 1989 Apr; 124(4):1849-56. PubMed ID: 2466638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism by which calcitonin gene-related peptide antagonizes insulin action in vivo.
    Choi SB; Frontoni S; Rossetti L
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E321-5. PubMed ID: 1996634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog.
    Buchs A; Märki F; Keller U
    Regul Pept; 1982 Aug; 4(3):117-26. PubMed ID: 6127755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of a central inhibition of growth hormone secretion by calcitonin gene-related peptide.
    Netti C; Guidobono F; Sibilia V; Pagani F; Braga PC; Pecile A
    Neuroendocrinology; 1989 Mar; 49(3):242-7. PubMed ID: 2785661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep.
    Bryce D; Yeh M; Funderburk C; Todd H; Hertelendy F
    Diabetes; 1975 Sep; 24(9):842-50. PubMed ID: 169176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
    Johnson DG; Ensinck JW; Koerker D; Palmer J; Goodner CJ
    Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galanin: effects on basal and stimulated insulin and glucagon secretion in the mouse.
    Lindskog S; Ahrén B
    Acta Physiol Scand; 1987 Mar; 129(3):305-9. PubMed ID: 2437768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of PYY and PP on endocrine pancreas.
    Szecówka J; Tatemoto K; Rajamäki G; Efendić S
    Acta Physiol Scand; 1983; 119(2):123-6. PubMed ID: 6362333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of theophylline on insulin, glucagon and somatostatin secretion from the isolated rat pancreatico-duodenal preparation.
    Kudo M; Kimura K; Masuda M; Sasaki S; Sawano S; Takebe K
    Endocrinol Jpn; 1981 Feb; 28(1):9-16. PubMed ID: 6113955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Action of [3,14-L-selenocysteine, 8-D-tryptophan]-somatostatin on insulin and glucagon secretion of the isolated perfused pancrease of the Wistar rat].
    Bierwolf B; Hartrodt B; Neubert R; Jakubke HD; Blech W
    Biomed Biochim Acta; 1986; 45(5):611-8. PubMed ID: 2875714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANF inhibits glucose-stimulated insulin secretion in mouse and rat.
    Ahrén B
    Am J Physiol; 1988 Nov; 255(5 Pt 1):E579-82. PubMed ID: 2973242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.